CD40LG and pneumonia: Severity of pneumonia was commonly involved in the prediction of slow treatment response to MP pneumonia in both the AUCs, whereas MP-specific IgM was commonly involved in the prediction of no response or progression of MP pneumonia in both the AUCs.